Stock Analysis

ISE Chemicals First Quarter 2025 Earnings: EPS: JP¥267 (vs JP¥172 in 1Q 2024)

TSE:4107
Source: Shutterstock

ISE Chemicals (TSE:4107) First Quarter 2025 Results

Key Financial Results

  • Revenue: JP¥8.24b (up 20% from 1Q 2024).
  • Net income: JP¥1.36b (up 56% from 1Q 2024).
  • Profit margin: 17% (up from 13% in 1Q 2024). The increase in margin was driven by higher revenue.
  • EPS: JP¥267 (up from JP¥172 in 1Q 2024).
Our free stock report includes 2 warning signs investors should be aware of before investing in ISE Chemicals. Read for free now.
earnings-and-revenue-growth
TSE:4107 Earnings and Revenue Growth May 1st 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

ISE Chemicals Earnings Insights

Looking ahead, revenue is forecast to stay flat during the next 2 years compared to a 4.7% growth forecast for the Chemicals industry in Japan.

Performance of the Japanese Chemicals industry.

The company's shares are up 14% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 2 warning signs for ISE Chemicals (1 doesn't sit too well with us!) that you need to be mindful of.

If you're looking to trade ISE Chemicals, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

Sponsored Content

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.